Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is BioForce Nanosciences Holdings EV-to-EBITDA?
BioForce Nanosciences HoldingsBFNH -4.76%32 EV-to-EBITDA is -84.74 as of Jul. 27, 2026. GuruFocus rates BFNH with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,643 Consumer Packaged Goods companies, BioForce Nanosciences Holdings ranks worse than 60864.21% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BioForce Nanosciences Holdings's enterprise value is $40.25 Mil.
BioForce Nanosciences Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.48 Mil. Therefore, BioForce Nanosciences Holdings's EV-to-EBITDA for today is -84.74.
The historical rank and industry rank for BioForce Nanosciences Holdings's EV-to-EBITDA or its related term are showing as below:
BFNH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -13495.57 Med: -1798.46 Max: -64.46
Current: -84.74
During the past 13 years, the highest EV-to-EBITDA of BioForce Nanosciences Holdings was -64.46. The lowest was -13495.57. And the median was -1798.46.
BFNH's EV-to-EBITDA is ranked worse than 100% of 1643
companies
in the Consumer Packaged Goods industry
Industry Median: 9.04
vs BFNH: -84.74
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BioForce Nanosciences Holdings's PE Ratio (TTM) for today is calculated as:
BioForce Nanosciences Holdings's share price for today is $1.20.
BioForce Nanosciences Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, BioForce Nanosciences Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioForce Nanosciences Holdings EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BioForce Nanosciences Holdings's EV-to-EBITDA falls into.
BioForce Nanosciences Holdings's current Enterprise Value is $40.25 Mil.
BioForce Nanosciences Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioForce Nanosciences Holdings (BFNH) has a EV-to-EBITDA of -84.74 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BioForce Nanosciences Holdings. According to the industry distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1643 companies in the Consumer Packaged Goods industry.
Is BioForce Nanosciences Holdings' EV-to-EBITDA too high?
BioForce Nanosciences Holdings' current EV-to-EBITDA is -84.74. Based on the distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1643 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, BioForce Nanosciences Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' EV-to-EBITDA compare to BHST and LSF?
According to the Consumer Packaged Goods industry distribution chart, BioForce Nanosciences Holdings ranks #999999 out of 1643 companies for EV-to-EBITDA. This places BioForce Nanosciences Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 9.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.04, based on 1,643 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BioForce Nanosciences Holdings. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioForce Nanosciences Holdings's current EV-to-EBITDA is -84.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current EV-to-EBITDA of -84.74. The current EV-to-EBITDA is -84.74. BioForce Nanosciences Holdings' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current EV-to-EBITDA is -84.74 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioForce Nanosciences Holdings Business Description
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
32GF Score
Get the complete analysis for BFNH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFNH has been successfully added to your 
